Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study

Yoshikazu Kinoshita(Shimane University), Motoyasu Kusano(Gunma University Hospital), Hisanori Abe(Imari Arita Kyoritsu Hospital), Hironori Masuyama(Saiseikai Matsuyama Hospital), Mitsuhiro Fujishiro(Bunkyo University), Seiichiro Hojo, Shinji Kumagai(University of Occupational and Environmental Health Japan), Mototsugu Kato(The Japanese Society of Gastroenterological Surgery), Ryo Nakata(Japanese Red Cross Medical Center), Yoshiumi Okubo(EA Pharma (Japan)), Yasushi Fukushima(Fukuda Denshi (Japan))
Journal of Gastroenterology
November 29, 2017
Cited by 30


Related Papers